Dominic F. Labriola
Corporate Officer/Principal presso MADRIGAL PHARMACEUTICALS, INC.
Posizioni attive di Dominic F. Labriola
Società | Posizione | Inizio | Fine |
---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 10/01/2022 | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | 10/01/2023 | - |
Storia della carriera di Dominic F. Labriola
Formazione di Dominic F. Labriola
University of Delaware | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Dominic F. Labriola
- Esperienza